Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2016-09-20
Original SEC Filing: Click here

---

Webplus: CBPO/20160920/8-K/2_EX-99.1/000.htm SEC Original: v449084_ex99-1.htm
China Biologic Receives CFDA Clinical Trial Approval for Human Coagulation Factor IX BEIJING, Sept. 19, 2016 /PRNewswire/ — China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that Shandong Taibang Biological Products Co. Ltd., the Company’s majority-owned subsidiary, recently obtained approval from the China Food and Drug

---

---

Webplus: CBPO/20160920/8-K/1/000.htm SEC Original: v449084_8k.htm

---

Company Information:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2016-09-20CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING, 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
BEIJING 100125